Day One Expands Pipeline with Potential First-in-Class Clinical-Stage ADC Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers June 25, 2024
LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial June 25, 2024
Lead Selection for MDG2021 Announced, Expanding TCR-T KRAS Library Targeting Solid Tumors June 25, 2024
Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib June 18, 2024
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors June 18, 2024
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial June 18, 2024
Immutep and MSD to Evaluate Efti in Combination with KEYTRUDA in Pivotal Ph 3 TACTI-004 Trial June 11, 2024
FibroGen Announces Clinical Trial Supply Agreement with Regeneron to Evaluate FG-3165 and FG-3175 in Combination with LIBTAYO in Upcoming Clinical Trials June 11, 2024
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development June 11, 2024
Ipsen and Marengo Therapeutics announce second strategic partnership to advance precision T cell engagers from Marengo’s Tri-STAR platform June 11, 2024
QUANTRO Therapeutics Reaches A Milestone In The Collaboration With Boehringer Ingelheim To Develop First-In-Class Cancer Treatments June 11, 2024
I-Mab Announces Collaboration with BMS to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers June 11, 2024
Notice of Allowance issued for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Various Solid Cancer June 11, 2024
Alphamab Oncology Collaborated with ArriVent in relation to the Research, Development and Commercialization of ADC Products June 11, 2024
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 June 11, 2024
Adaptimmune and Galapagos Collaborate on uza-cel in Head & Neck Cancer and Potential Future Solid Tumor Indications June 4, 2024
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt June 4, 2024
Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology June 3, 2024
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs June 3, 2024
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS(TM) First in Human Study June 3, 2024
Dragonfly Announces Clinical Collaboration to Evaluate DF9001 in Combination with KEYTRUDA® in Patients with Solid Tumors May 29, 2024
Nanobiotix and Janssen aligned at the collaboration’s Joint Strategy Committee to transfer the global sponsorship of the Ph 3 pivotal head and neck cancer trial May 29, 2024
